fluorodeoxyglucose f18 has been researched along with vigabatrin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben-Menachem, E; Dean, A; Fazilat, S; Gaillard, WD; Kopylev, L; Liow, K; Siegel, H; Spanaki, MV; Theodore, WH | 1 |
| Al-Essa, MA; Bakheet, SM; Ozand, PT; Patay, ZJ; Powe, JE | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and vigabatrin
| Article | Year |
|---|---|
The effect of vigabatrin (gamma-vinyl GABA) on cerebral blood flow and metabolism.
Topics: Adult; Anticonvulsants; Brain; Cerebrovascular Circulation; Double-Blind Method; Epilepsy, Complex Partial; Female; Fluorodeoxyglucose F18; gamma-Aminobutyric Acid; Glucose; Humans; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Vigabatrin | 1999 |
1 other study(ies) available for fluorodeoxyglucose f18 and vigabatrin
| Article | Year |
|---|---|
Clinical, fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography (FDG PET), MRI of the brain and biochemical observations in a patient with 4-hydroxybutyric aciduria; a progressive neurometabolic disease.
Topics: Brain; Child, Preschool; Dextromethorphan; Fluorodeoxyglucose F18; Humans; Hydroxybutyrates; Magnetic Resonance Imaging; Male; Metabolism, Inborn Errors; Saudi Arabia; Tomography, Emission-Computed; Vigabatrin | 2000 |